תבנית:תרופה/לבטיראצטם דקסל 750 - Levetiracetam dexcel 750
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× |
|
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | N03AX Other antiepileptics |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××, TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:⢠In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.⢠In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.⢠In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
|
| ת×× ×ת:× ×ª×× × ×¡×/תר×פ×/××××ר×צ×× ××§×¡× 750 - Levetiracetam dexcel 750 | |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× |
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ××××ר×צ×× ××§×¡× 750 ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | - |
|---|---|
| ××××¢ ×רשת | - |
| ×©× ××¦×¨× | DEXCEL LTD, ISRAEL |
| ×©× ××¢× ×ר×ש×× | DEXCEL PHARMA TECHNOLOGIES LTD |
| ר×ש××× | ת×ר×× ××ש×: 06/2011. ר×ש××× ×ת×ר××: 03/2018 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
××£ ×× × ×צר ×¢× ××× ××× ×××××ר ת×× ×ת ×¢× ×¤×¨×× ×תר×פ×.
- ××£ ×תר×פ×: ××××ר×צ×× ××§×¡× 750 - Levetiracetam dexcel 750
- ××ר××¡× ××× ×ת ×©× ×¤×¨×× ×תר×פ×: × ××ª× ×ער×× ×ת ××£ ×תר××¤× ××¢××. ×××××× ×××××¤× ×ת:
{{תר×פ×/××××ר×צ×× ××§×¡× 750 - Levetiracetam dexcel 750}}
×:
{{תר×פ×/××××ר×צ×× ××§×¡× 750 - Levetiracetam dexcel 750
| ×©× ×פר××ר=×¢×¨× ××ש (××רס ×ת ××¢×¨× ×©×××× ××××ר)
}}
השינוי האחרון נעשה בֹ־1 במרץ 2024 ב־04:05